Although propranolol is a beta blocker which is mainly used for the treatment of hypertension, atrial fibrillation, and other arrhythmias; it has been shown to decrease VEGF levels in recent years, especially through the P3K/Akt/Enos/VEGF pathway [21, 22]. This evidence concerns the gene VEGFA and atrial fibrillation.